Related Experiment Video
Updated: Jul 27, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Inhibition of myocardial endothelin pathway improves long-term survival in heart failure
S Sakai1, T Miyauchi, M Kobayashi
1Cardiovascular Division, Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan.
Insights
Blocking endothelin-1 receptors improved survival in rats with chronic heart failure. This treatment also reduced heart dysfunction and prevented adverse cardiac remodeling, suggesting a new therapeutic target for heart failure.
Area of Science:
- Cardiovascular Biology
- Heart Failure Pathophysiology
- Endothelin System
Background:
- Coronary artery occlusion leads to myocardial infarction, increasing chronic heart failure risk.
- Endothelin-1, produced by cardiac myocytes and endothelial cells, enhances contractility but also causes hypertrophy and injury.
- Elevated endothelin-1 in heart failure suggests a role in supporting cardiac function, but its long-term impact is debated.
Purpose of the Study:
- To investigate the long-term effects of endothelin-receptor antagonism on chronic heart failure progression.
- To determine if blocking the endothelin system could improve survival and cardiac function in a rat model of heart failure.
Main Methods:
- Utilized a rat model of chronic heart failure following myocardial infarction.
- Administered an endothelin-receptor antagonist over the long term.
- Assessed survival rates, left ventricular function, and ventricular remodeling.
Main Results:
- Long-term treatment with an endothelin-receptor antagonist significantly improved survival in rats with chronic heart failure.
- The antagonist treatment led to a significant amelioration of left ventricular dysfunction.
- Prevention of ventricular remodeling, characterized by reduced ventricular mass and cavity enlargement, was observed.
Conclusions:
- Upregulation of the myocardial endothelin system contributes to the progression of chronic heart failure.
- Long-term blockade of endothelin receptors offers a promising therapeutic strategy for improving outcomes in chronic heart failure.
- Targeting the endothelin system may mitigate adverse cardiac remodeling and preserve cardiac function in heart failure.
Abstract:
Occlusion of the diseased coronary artery in humans causes acute myocardial infarction, survivors of which have a high risk for the development of chronic heart failure. Cardiac myocytes and vascular endothelial cells produce endothelin-1 (refs 2-4), which increases the contractility of cardiac muscle and of vascular smooth muscle cells. Endothelin-1 also exerts long-term effects such as myocardial hypertrophy, and causes cellular injury in cardiac myocytes. Production of endothelin-1 is markedly increased in the myocardium of rats with heart failure, and acute application of an endothelin-receptor antagonist decreases myocardial contractility in such rats, indicating that myocardial endothelin-1 may help to support contractility of the failing heart. But we report here that the upregulated myocardial endothelin system may contribute to the progression of chronic heart failure, because long-term treatment with an endothelin-receptor antagonist greatly improved the survival of rats with chronic heart failure. This beneficial effect was accompanied by significant amelioration of left ventricular dysfunction and prevention of ventricular remodelling, in which there is usually an increase in the ventricular mass and cavity enlargement of the ventricle.
More Related Videos
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Heart Failure VII: Nursing Interventions
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VI: Nursing Management

